RGABX
Price
$64.26
Change
-$1.38 (-2.10%)
Updated
Sep 6 closing price
VAFNX
Price
$27.71
Change
-$0.70 (-2.46%)
Updated
Sep 6 closing price
Ad is loading...

RGABX vs VAFNX

Header iconRGABX vs VAFNX Comparison
Open Charts RGABX vs VAFNXBanner chart's image
American Funds Growth Fund of Amer R2
Price$64.26
Change-$1.38 (-2.10%)
VolumeN/A
CapitalizationN/A
Invesco American Franchise R5
Price$27.71
Change-$0.70 (-2.46%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RGABX vs VAFNX Comparison Chart
Loading...
VS
RGABX vs. VAFNX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGABX is a Buy and VAFNX is a Buy.

FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 270B vs. VAFNX (14.8B). RGABX (0.00) and VAFNX (0.00) have matching dividends . RGABX was incepted earlier than VAFNX: RGABX (22 years) vs VAFNX (14 years). VAFNX is a more actively managed with annual turnover of: 73.00 vs. RGABX (31.00). RGABX has a lower initial minimum investment than VAFNX: RGABX (250) vs VAFNX (1000000). VAFNX annual gain was more profitable for investors over the last year : 27.46 vs. RGABX (16.73). RGABX return over 5 years is better than : 39.81 vs. VAFNX (27.69).
RGABXVAFNXRGABX / VAFNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years14 years-
Gain YTD14.97618.32682%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets270B14.8B1,824%
Annual Yield % from dividends0.000.00-
Returns for 1 year16.7327.4661%
Returns for 3 years-10.52-17.8059%
Returns for 5 years39.8127.69144%
Returns for 10 years45.3855.3382%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRDG8.090.12
+1.51%
Bridge Investment Group Holdings
IR87.610.35
+0.40%
Ingersoll Rand
TPCS3.310.01
+0.30%
TechPrecision Corp
ALEX19.35-0.05
-0.26%
Alexander & Baldwin
AXSM93.69-1.87
-1.96%
Axsome Therapeutics